SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%
新闻
QURE
--
0.00%
--
Hedge Funds Done Buying Uniqure NV (QURE)?
Insider Monkey · 2天前
Analysts Have Just Cut Their uniQure N.V. (NASDAQ:QURE) Revenue Estimates By 16%
Simply Wall St. · 05/18 12:49
uniQure Highlights Presentations For ASGCT Meeting
 uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, presented new preclinical data on its gene therapy candidates AMT-150 for
Benzinga · 05/14 11:12
uniQure Presents New Preclinical Data in SCA3, Fabry Disease, and Hemophilia A at the ASGCT Annual Meeting
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, May 14, 2020 (GLOBE NEWSWIRE) --  uniQure N.V. (QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, presented new preclinical data on its gene thera
GlobeNewswire · 05/14 11:00
UniQure (QURE) Reports Q1 Loss, Misses Revenue Estimates
Zacks · 04/29 13:45
uniQure Announces First Quarter 2020 Financial Results and Highlights Recent Company Progress
GlobeNewswire · 04/29 12:00
uniQure Q1 EPS $(0.630) Up From $(0.740) YoY
uniQure (NASDAQ:QURE) reported quarterly losses of $(0.630) per share. This is a 14.86 percent increase over losses of $(0.740) per share from the same period last year.
Benzinga · 04/29 11:11
uniQure Announces Significant Presence at Upcoming American Society of Gene and Cell Therapy (ASGCT) Virtual Annual Meeting
GlobeNewswire · 04/28 21:51
Earnings Preview: uniQure (QURE) Q1 Earnings Expected to Decline
UniQure (QURE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 04/27 16:32
Why Sanofi CEO's Comments Lit A Fire Under Gene Therapy Stocks
Investor's Business Daily · 04/24 21:21
uniQure Shares Volatile On Uptick In Volume; Hearing Cantor Fitzgerald Out With Positive Comments On Name
-TradeXchange
TradeXchange · 04/24 17:49
Does uniQure (NASDAQ:QURE) Have A Healthy Balance Sheet?
Simply Wall St. · 04/21 15:47
uniQure Announces the Nomination of Leonard E. Post, Ph.D. to its Board of Directors
GlobeNewswire · 04/17 12:00
uniQure (QURE) Investor Presentation - Slideshow
Seeking Alpha - Article · 04/07 20:19
FDA OKs new hemophilia treatment
Seeking Alpha - Article · 04/01 17:51
uniQure to Participate in Multiple Upcoming Investor Conferences in April
GlobeNewswire · 03/30 12:00
Hedge Funds Have Never Been This Bullish On Uniqure NV (QURE)
Insider Monkey · 03/29 01:10
Stocks To Watch: Investors Stay The Distance
Seeking Alpha - Article · 03/28 13:04
Biotech delays U.S. gene therapy launch due to outbreak, FDA discord
American City Business Journals · 03/26 17:36
UniQure hits enrollment target in late-stage study of hemophilia B gene therapy
Seeking Alpha - Article · 03/26 11:35